PGIM Jennison Health Sciences Fund - Class R (PJHRX)
| Fund Assets | 1.36B |
| Expense Ratio | 1.48% |
| Min. Investment | $0.00 |
| Turnover | 79.00% |
| Dividend (ttm) | 5.20 |
| Dividend Yield | 17.54% |
| Dividend Growth | 171.88% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 29.33 |
| YTD Return | -5.91% |
| 1-Year Return | -2.31% |
| 5-Year Return | 47.09% |
| 52-Week Low | 27.23 |
| 52-Week High | 40.92 |
| Beta (5Y) | n/a |
| Holdings | 45 |
| Inception Date | Feb 3, 2012 |
About PJHRX
The PGIM Jennison Health Sciences Fund is a mutual fund focused on achieving long-term capital appreciation by predominantly investing in companies within the healthcare, biotech, and pharmaceutical sectors. This fund targets equity-related securities of U.S. firms involved in industries such as hospitals, health insurance providers, pharmaceutical companies, and medical equipment manufacturers. By concentrating on these sectors, the fund provides a strategic investment opportunity for those interested in the healthcare and biotechnology industries. The fund's high-conviction approach is managed by experienced healthcare specialists, making it a notable player in the financial market for investors seeking exposure to these rapidly evolving sectors.
Performance
PJHRX had a total return of -2.31% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.98%.
Top 10 Holdings
57.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.60% |
| Prudential Govt Money Mkt Fd | n/a | 10.96% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.95% |
| argenx SE | ARGX | 4.85% |
| Neurocrine Biosciences, Inc. | NBIX | 4.78% |
| AstraZeneca PLC | AZN | 4.64% |
| Thermo Fisher Scientific Inc. | TMO | 3.58% |
| Novo Nordisk A/S | NVO | 3.50% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 3.15% |
| UnitedHealth Group Incorporated | UNH | 2.85% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 20, 2024 | $5.20167 | Dec 20, 2024 |
| Dec 20, 2023 | $1.91322 | Dec 20, 2023 |
| Dec 20, 2022 | $0.61624 | Dec 20, 2022 |
| Dec 20, 2021 | $14.02528 | Dec 20, 2021 |
| Dec 20, 2019 | $1.43164 | Dec 20, 2019 |
| Dec 20, 2018 | $4.77761 | Dec 20, 2018 |